All Stories

  1. Modern challenges in infection prevention: encapsulated organisms in the era of novel complement inhibitors
  2. Current trial landscape of IgA nephropathy therapy
  3. Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy
  4. Clinical and Humanistic Burden of IgAN in Adult Patients
  5. Current Biomarkers of IgA Nephropathy
  6. Stop Sitting on Our “RAASes”
  7. Considering the Treatment of IgA Nephropathy
  8. pSTAT1 Is Activated during the Progression of IgA Nephropathy
  9. JAK-STAT Activity in Peripheral Blood Cells and Kidney Tissue in IgA Nephropathy
  10. Facing the Vexing Problem of Recurrent FSGS after Kidney Transplantation
  11. Corticosteroids for IgA Nephropathy
  12. Baseline and early outcomes in glomerular disease patients
  13. Patient Characteristics and Outcomes by GN Subtype in ESRD
  14. Mapping Novel Immunogenic Epitopes in IgA Nephropathy
  15. Immunoglobulin A nephropathy: insights and progress
  16. Treatment of Idiopathic FSGS with Adrenocorticotropic Hormone Gel
  17. Renal Physiology of Pregnancy
  18. ASN Kidney Week
  19. Nephrologists and Sepsis
  20. Blood Pressure Goals in CKD: Where Are We Going, and How Do We Get There?
  21. Acute Kidney Injury: We Must Do Better
  22. Withholding or Withdrawing Dialysis in the ICU: Whatʼs Your Policy?
  23. AKI in the Pregnant Patient: Two Lives at Stake
  24. The kidney in preeclampsia
  25. Pharmacologic Interventions in Acute Renal Failure